Abstract
Hydroxycarbamide (HC) is the first-line treatment for certain myeloproliferative neoplasms, such as polycythemia vera and essential thrombocytosis (ET). In a subset of these patients long-term treatment with HC can result in the development of confluent actinic keratoses (AK) followed by invasive keratinocytic carcinomas ("squamous dysplasia"), preferentially on sun-exposed skin. Discontinuation or dose reduction of HC may result in partial improvement. A 59-year-old farmer after 14 years on HC (2 gr/d) and acetylsalicylic acid (100 mg/d) for ET, was referred for numerous, hyperkeratotic AK on face, scalp, and hands that could not be controlled with repeated (N = 15) cryosurgery sessions in the previous 3 years. Acitretin (0.32 mg/kg daily) and topical treatments (cryosurgery with ingenol mebutate) were initiated with only marginal improvement after 3 months. Acitretin dose was doubled and HC was switched to anagrelide (0.5 mg twice daily). Within a month the AK load regressed significantly and, at 3 months follow-up, complete clinical remission was achieved and acitretin was discontinued. Twenty months later the patient is clear from AK. In conclusion, the impressive and sustainable AK remission under anagrelide draws attentio...Continue Reading
References
Jan 1, 1988·Experimental Cell Research·B Maurer-SchultzeI D Bassukas
Jan 1, 1982·Carcinogenesis·O H Iversen
Oct 27, 1998·Mayo Clinic Proceedings·P J Best, R M Petitt
Jul 29, 2004·Journal of the American Academy of Dermatology·Carla Sanchez-Palacios, Joan Guitart
Mar 2, 2012·Current Problems in Dermatology·Bahar Shafaeddin SchreveUNKNOWN working group Organ Transplantation, Swiss Society for Dermatology and Venerology
Apr 5, 2012·American Journal of Hematology·Elisabetta AntonioliUNKNOWN AGIMM Investigators
Feb 12, 2014·Dermatology Research and Practice·Aimen Ismail, Nabiha Yusuf
Apr 2, 2014·Nature Reviews. Drug Discovery·Donald H MauriceVincent C Manganiello
Oct 21, 2014·PloS One·Jamie J BernardYao-Ping Lu
May 23, 2015·European Journal of Haematology·Montse GómezJuan-Carlos Hernández-Boluda
Dec 15, 2015·Nature Chemical Biology·Luc de WaalMatthew Meyerson
Aug 16, 2016·Clinical Lymphoma, Myeloma & Leukemia·Carlos Besses, Alberto Alvarez-Larrán
Nov 7, 2017·Experimental Cell Research·Madiha NazirMårten Fryknäs
Jan 13, 2018·Blood Cancer Journal·Ayalew TefferiTiziano Barbui